概括
克洛扎的使用可能会增加静脉血栓栓塞并发症的风险,例如血栓. 这项研究审查了12起案件,其中5起导致死亡,突出了严重的潜在不良影响.
科学领域:
- 药物监督 药物监督 药物监督
- 临床毒理学 临床毒理学
- 血液学 血液学 血液学
背景情况:
- 克洛扎是一种非典型的抗精神病药物,用于治疗耐药精神分裂症.
- 静脉血栓塞栓症 (VTE) 包括深静脉血栓和肺栓塞.
- 药物不良反应需要持续监测和报告.
研究的目的:
- 调查克洛扎治疗与静脉血栓栓塞并发症之间的关联.
- 在接受克洛扎的患者中总结了VTE的病例报告.
主要方法:
- 审查向瑞典不良反应咨询委员会提交的病例数据.
- 对12例已报道的血栓塞栓症病例的分析,这些病例发生在用克洛札治疗的患者中.
主要成果:
- 在审查的病例中,克洛扎的使用与静脉血栓栓塞并发症有关.
- 在克洛扎治疗期间报告的12例VTE病例中,有5例是致命的.
结论:
- 这些发现表明,克洛沙平与VTE风险增加之间存在潜在联系.
- 医疗保健提供者应警用克洛扎治疗的患者出现VTE的迹象.
- 需要进一步的研究来阐明机制并确认这种关联.
相关概念视频
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...


